Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Insulet Corp (NQ: PODD ) 205.15 +0.73 (+0.36%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Insulet Corp < Previous 1 2 3 4 5 6 7 Next > Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally December 17, 2022 UnitedHealth is among medical stocks holding key support. Via Investor's Business Daily 2 Best Medical Device Stocks for 2023 December 08, 2022 Insulet and Conmed ought to be medtech's shining stars in 2023. Via The Motley Fool Looking Into Insulet's Return On Invested Capital November 21, 2022 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session November 17, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Insulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging November 15, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 04, 2022 Gainers Via Benzinga Why Insulet Stock Is Skyrocketing Today November 04, 2022 Investors are cheering the company's strong Q3 results. Via The Motley Fool Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance November 04, 2022 Via Benzinga Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday November 07, 2022 Gainers Via Benzinga FDA Approves Insulet's Omnipod Automated Insulin System For Patients Two Years & Above August 22, 2022 Via Benzinga Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session November 04, 2022 Gainers Via Benzinga What 8 Analyst Ratings Have To Say About Insulet August 05, 2022 Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter: Via Benzinga Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance August 05, 2022 Via Benzinga Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday November 04, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga What 5 Analyst Ratings Have To Say About Insulet November 04, 2022 Over the past 3 months, 5 analysts have published their opinion on Insulet (NASDAQ:PODD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 04, 2022 Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022 November 04, 2022 Upgrades Via Benzinga Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket November 04, 2022 Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday. Via Benzinga Coinbase, DoorDash And Some Other Big Stocks Moving Higher In Today's Pre-Market Session November 04, 2022 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 October 18, 2022 Upgrades Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 October 12, 2022 Upgrades Via Benzinga Analyst Ratings for Insulet October 12, 2022 Over the past 3 months, 6 analysts have published their opinion on Insulet (NASDAQ:PODD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Neurocrine Leads 5 Stocks To Watch In Sickly Market September 03, 2022 Neurocrine Biosciences leads five medical stocks showing resilience. Via Investor's Business Daily A Bullish Sign Appears On Insulet's Chart September 01, 2022 If history is any guide, there may be good fortune ahead for shares of Insulet (NASDAQ:PODD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the... Via Benzinga $1000 Invested In Insulet 5 Years Ago Would Be Worth This Much Today August 23, 2022 Insulet (NASDAQ:PODD) has outperformed the market over the past 5 years by 24.25% on an annualized basis producing an average annual return of 35.42%. Currently, Insulet has a market capitalization of... Via Benzinga Recap Of Monday's Biotech Catalysts - End Of the Day Summary August 22, 2022 Via Benzinga Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22 August 22, 2022 Reuters Vodafone To Sell Hungarian Business For $1.8B: Report Via Benzinga FDA Clears Insulet's Omnipod 5 Automated Insulin Delivery System For Preschool Children August 22, 2022 The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with... Via Benzinga Recap: Insulet Q2 Earnings August 04, 2022 Insulet (NASDAQ:PODD) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Insulet missed estimated earnings by... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022 July 11, 2022 Upgrades Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.